BrainLine Military

A Service of

Turn off text only

Page Utilities


Almost a Perfect Storm: Therapy for TBI

Almost a Perfect Storm: Therapy for TBI

Click on any phrase to play the video at that point.
[Dr. Geoffrey Ling] So, for what reasons am I optimistic that we will actually have a meaningful therapy for traumatic brain injury within the next few years? I think it's based upon my understanding of where the science has evolved to. We are now understanding a lot about how physical forces injure the brain. So, that gives us an opportunity—now that we know how they do it— now we know how to prevent it. We now know a lot about the biochemical and cellular effects of a brain injury and how they evolve. And that's in fact where drugs have to work— they work at the cellular and the biochemical levels. So, now that you know how this process is going, you can now intercede appropriately. And that's the work of the pharmacologists as they develop new drugs. Already there are some promising drugs out there. Progesterone is a classic example. That drug is actually in phase 2 clinical trials right now because it already looked very promising in its phase 1. Phase 1 was a safety trial, but it still looked very, very good. And now there is a large trial going on so we're very hopeful. But there are others on the way right behind it based upon our better understanding of the cellular and chemical processes of brain injury. And finally, public awareness. This is no small thing; the public has to work with us to help us reduce the risks and the risky behaviors associated with brain injuries. So, all of these things are coming to pass right now together. It's almost a perfect storm.

show transcriptShow transcript | Print transcript

With the burgeoning understanding of the cellular and biochemical effects of brain injury, pharmacologists can successfully intercede with more promising standardized treatment.

See more videos with Dr. Geoffrey Ling>>


Produced by Noel Gunther, Ashley Gilleland, and Erica Queen, BrainLine.

Geoffrey Ling, MD, PhD, Col. (Ret.)Geoffrey Ling, MD, PhD, Col. (Ret.), Geoffrey Ling, MD, PhD is a program manager at the Defense Advanced Research Projects Agency, where he has responsibility for a broad research portfolio. Dr. Ling is an authority on traumatic brain injury, especially as it pertains to the military.

The contents of BrainLine Military (the “Web Site”), such as text, graphics, images, information obtained from the Web Site’s licensors and/or consultants, and other material contained on the Web Site (collectively, the “Content”) are for informational purposes only. The Content is not intended to be a substitute for medical, legal, or other professional advice, diagnosis, or treatment.

Specifically, with regards to medical issues, always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on the Web Site. If you think you may have a medical emergency, call your doctor or 911 immediately. The Web Site does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the Web Site. Reliance on any information provided by the Web Site or by employees, volunteers or contractors or others associated with the Web Site and/or other visitors to the Web Site is solely at your own risk.


There are currently no comments for this article


BrainLine Footer

Javascript is disabled. Please be aware that some parts of the site may not function as expected!